好药价 GDRX

Wendy Barnes has served as a member of our Board since January 2025 and currently serves as our President and Chief Executive Officer. Previously, Ms. Barnes served as Chief Executive Officer of RxBenefits, Inc., a pharmacy benefits optimizer, from May 2022 to December 2024. From July 2013 to April 2022, Ms. Barnes held various roles at Express Scripts Holding Company, a pharmacy benefit management organization, including most recently as the President of Express Scripts Pharmacy from August 2019 to April 2022. Ms. Barnes holds a B.S. degree in Biochemistry from the United States Air Force Academy and an M.B.A. degree from the University of Alaska at Anchorage.

Trevor Bezdek is one of our co-founders and has served as a member of our Board since our founding in September 2011. Mr. Bezdek served as our Chairman of the Board from April 2023 to January 2025 and has served as our Co-Chairman of the Board since January 2025. Previously, Mr. Bezdek was a Co-Chief Executive Officer and the Secretary of the Company from January 2015 to April 2023. Prior to that, Mr. Bezdek served as Managing Partner at Tryarc, LLC, an information technology consulting firm, from 2001 to 2007, and co-founded Biowire, a bioinformatics software provider and community for biologists and scientists. Mr. Bezdek holds a B.S. in Biological Sciences from Stanford University.

Scott Wagner has served as Co-Chairman of the Board since January 2025. Mr. Wagner previously served as our Interim Chief Executive Officer from April 2023 to January 2025. Prior to that, he held various executive roles at GoDaddy Inc. (GoDaddy), an internet domain and webhosting company, from 2012 to 2019 including Chief Executive Officer and President/Chief Financial Officer/Chief Operating Officer. Mr. Wagner joined GoDaddy from global private equity and investment firm KKR & Co. Inc. where he was a Partner and worked from 2000 to 2012 as one of the leads of KKR's Capstone team. Mr. Wagner has served on the board of directors of public companies DoubleVerify Holdings, Inc. since October 2021 and Bill Holdings, Inc. from September 2021 to February 2025. Mr. Wagner holds a B.A. degree in Economics from Yale University and an M.B.A. degree from Harvard Business School.

Ronald E. Bruehlman has served as a member of our Board since November 2024. Mr. Bruehlman is a Senior Advisor to the CEO at IQVIA, a leading global provider of clinical research services, commercial insights, and healthcare intelligence to the life sciences and health care industries. , He has been at IQVIA since 2016 and served as the Chief Financial Officer from August 2020 to February 2026. Prior to IQVIA, Mr. Bruehlman served as Chief Financial Officer of IMS Health from July 2011 to September 2016 and had a 23-year career at United Technologies Corporation, where he held multiple senior finance leadership roles of increasing responsibility. Mr. Bruehlman previously served on the board of directors of Atotech Ltd., Q-Squared Solutions, and Clipper Windpower. Mr. Bruehlman holds a B.S. in Economics from the University of Delaware, as well as an MBA in Finance from the University of Chicago, Booth School of Business.

Agnes Rey-Giraud has served as a member of our Board since June 2016. Ms. Rey-Giraud is the Founder of Acera Surgical Inc., a bioscience company, where she served as the Chairman from January 2013 to December 2025 and as the Chief Executive Officer from its founding in January 2013 until May 2022. Ms. Rey-Giraud previously served in multiple executive roles of increasing responsibility, including Executive Vice President and the President of International Operations, at Express Scripts Holding Company, a pharmacy benefit management organization. Ms. Rey-Giraud has served on the board of directors of UpHealth, Inc. from June 2021 to April 2025, where she served as a member of its audit committee and nominating and corporate governance committee. Ms. Rey-Giraud also serves on the board of directors for several private companies. Ms. Rey-Giraud holds a B.S. and M.S. in Mechanical Engineering from Ecole Nationale d'Ingenieurs de Saint Etienne (ENISE), France, an MMa in Operations Management from Ecole de Management de Lyon (EM Lyon), France and an M.B.A. from the University of Chicago.

Kelly J. Kennedy has served as a member of our Board since December 2023. Since November 2023, Ms. Kennedy has served as the Chief Financial Officer of ExploraMed NC7, Inc. d/b/a Willow Innovations, a women's health technology company that develops and markets breastfeeding and wearable pumping products. She previously served as Executive Vice President, Chief Financial Officer of The Honest Company, Inc., a personal care company (the Honest Company), from January 2021 to September 2023. Prior to joining the Honest Company, Ms. Kennedy served as Chief Financial Officer of The Bartell Drug Company, a family-owned pharmacy chain, from September 2018 until its sale to Rite Aid in December 2020. Ms. Kennedy has served as Chief Financial Officer for various private and public companies in the consumer space including Sur La Table, Inc., See's Candies and Annie's Inc. Ms. Kennedy has also served in various senior financial roles at Williams-Sonoma, Inc. and Dreyer's Grand Ice Cream Holdings, Inc. Currently, Ms. Kennedy serves on the board of directors of Vital Farms, Inc., since December 2019, where she is the chair of its audit committee and a member of its compensation committee. Ms. Kennedy also serves on the board of directors of Sattelogic, Inc., since September 2024, where she is the chair of its audit committee and a member of its finance committee. Ms. Kennedy also currently serves on the board of directors of several private companies, including FirstFruits Farms LLC, since December 2019, and Skinny Mixes LLC, since July 2023. Previously, Ms. Kennedy served on the board of directors of Sur La Table, Inc., from September 2018 to November 2020 and RAD Power Bikes from July 2021 to December 2025. Ms. Kennedy received her M.B.A. from Harvard Business School and her B.A. in Economics from Middlebury College.

Douglas Hirsch is one of our co-founders and has served as a member of our Board since our founding in September 2011. Previously, Mr. Hirsch was a Co-Chief Executive Officer of the Company from September 2011 to April 2023 and served as our Chief Mission Officer from April 2023 to October 2024. Prior to our founding, Mr. Hirsch served as Chief Executive Officer at DailyStrength, Inc., a provider of healthcare-focused online support groups, from March 2005 to November 2008, and previously held senior roles at Facebook, Inc. and Yahoo! Inc. Mr. Hirsch holds a B.A. in Political Science from Tufts University.

On August 2, 2026, the Board of Directors of the Company appointed Justin Fengler, the Company's current Chief Strategy & Operations Officer, to also serve as Chief Financial Officer & Treasurer of the Company, effective as of August 6, 2026. The Board designated Mr. Fengler as principal financial officer, effective as of the Effective Date. Mr. Fengler will continue to oversee the Company's strategy and operations.Mr. Fengler, 38, has served as the Company's Chief Strategy & Operations Officer since September 2025. Mr. Fengler has been with the Company since 2016. Prior to his current role, Mr. Fengler most recently served as the Company's Senior Vice President of Corporate Strategy & Business Operations, where he oversaw the Company's strategic initiatives, mergers and acquisitions, and executive operations, since 2018. Prior to joining the Company, Mr. Fengler was a healthcare investment banker with TripleTree from 2013 to 2016 and was a consultant with Oliver Wyman prior to that. Mr. Fengler holds degrees in business and international relations from the University of Arkansas.

Christopher Adams has served as a member of our Board since October 2015. Mr. Adams is a Partner at Francisco Partners Management, L.P. (Francisco Partners), a global investment firm that specializes in partnering with technology and technology-enabled businesses, where he has served since August 2008. Prior to this, Mr. Adams was an associate at American Securities Capital Partners, a private equity firm, and a management consultant at Bain & Company, Inc. Mr. Adams also serves on the board of directors of several private companies. Mr. Adams holds a B.S. in Computer Engineering from the Georgia Institute of Technology and an M.B.A. from the Stanford Graduate School of Business.

Gregory Mondre has served as a member of our Board since October 2018. Mr. Mondre is Co-Chief Executive Officer and Managing Partner at Silver Lake, a global technology investment firm. He joined Silver Lake in 1999 and most recently served as a Managing Partner and Managing Director of the firm from January 2013 to December 2019. Mr. Mondre currently serves on the board of directors of Motorola Solutions, Inc., a position he has held since August 2015 and where he also serves on its governance and nominating and compensation and leadership committees. He previously served as a director of Expedia Group, Inc. from May 2020 to October 2021 and of GoDaddy from May 2014 to February 2020. Mr. Mondre holds a B.S. degree in Economics from the Wharton School of the University of Pennsylvania.

On April 23, 2026, the Board of Directors of GoodRx Holdings, Inc. appointed Thomas Chan, Vice President, Corporate Controller of the Company as the Company's Chief Accounting Officer and designated Mr. Chan as the principal accounting officer of the Company, in each case effective immediately. Mr. Chan, 40, joined the Company in October 2020 and has served in various controllership and financial reporting roles, including as our Vice President, Corporate Controller from February 2024 to April 2026; Vice President, Accounting & Reporting from May 2023 to February 2024; Vice President, Financial Reporting & Quality from July 2022 to May 2023; and other accounting roles of increasing responsibility from October 2020 to July 2022. Prior to joining the Company, Mr. Chan served in various audit and assurance roles at Deloitte & Touche, LLP since July 2011, most recently as an Audit & Assurance Senior Manager. Mr. Chan holds a B.A. in Business Administration, with an emphasis in accounting, from California State University, Fullerton, and is a Certified Public Accountant in the State of California.